{"podcast":{"title":"The Fellow on Call: The Heme/Onc Podcast","slug":"the-fellow-on-call-the-heme-onc-podcast-4669989","podcast_index_feed_id":4669989,"rss_url":"https://www.thefellowoncall.com/tfocpodcast?format=rss","website_url":"https://www.thefellowoncall.com/tfocpodcast/","image_url":"https://images.squarespace-cdn.com/content/v1/61b273ac9be6aa2250498c9e/1641065434990-8BV6L7UFJF4JCCKCY6S1/Untitled+design+%281%29+copy.png?format=1500w","author":"Ronak Mistry","episode_count":164,"summary":"We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.","last_synced_at":"2026-06-24T18:17:58.817010+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989"},"episode":{"title":"Episode 156: Immune Thrombocytopenic Purpura Series, Pt 2- Relapsed/Refractory","slug":"episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory","published_at":"2026-06-24T08:00:57+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory","show_page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989","url":"https://www.thefellowoncall.com/tfocpodcast/itprelapsedrefractory","audio_url":"https://static1.squarespace.com/static/61b273ac9be6aa2250498c9e/t/6a3ac76bb1ad17039574c938/1782237053423/The+Fellow+On+Call+-+ITP+Second+Line+Therapies+-+Mix_Edited.mp3","summary":"This week, we move to the relapsed/refractory ITP setting, focusing on what options are available to patients after their initial treatment with steroids ± IVIg, which we discussed in Episode 155. If you have not done so already, definitely listen to that episode as we build on the topics discussed here today! Content: - What are options after steroids? - How to counsel patients on options? - Is there a correct way to sequence available options? ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Youtube","meta_description":"This week, we move to the relapsed/refractory ITP setting, focusing on what options are available to patients after their initial treatment with steroids…","key_points":[],"chapters":[],"topics":[],"duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-156-immune-thrombocytopenic-purpura-series-pt-2-relapsed-refractory.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}